0358US Non-Provisional Application for: METHOD AND COMPOSITION FOR NOVEL USE OF IGF-1 AND GARCINOL TO INDUCE CLINICAL WEIGHT LOSS
Publication # US2019/0358300 A1 Publication Date: November 28, 2019
Methods and compositions for treating patients with obesity or diabetes, or a combination thereof. Methods include administering to the patient a compound including a histone acetyltransferase inhibitor (iHAT), or an IgF-1 derivative, and a pharmaceutically acceptable carrier.
The contents of this web site, such as graphics, clinical information, tweets, and/or documents is for informational purposes only and does not replace professional treatment. There is nothing on this web site to constitute medical advice for human or companion animals. This website is not intended as a treatment for any medical diagnoses. If you or your companion animal has a medical condition please consult a licensed physician and/or veterinarian. Always consult with the appropriate professional for specific advice related to any medical condition. Note; that while every attempt was made to insure all information within is accurate, errors or omissions may be contained therein, for which any liability is disclaimed.